Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump.

Abstract:

:Imatinib mesylate (STI571), a potent tyrosine kinase inhibitor, is successfully used in the treatment of chronic myelogenous leukemia and gastrointestinal stromal tumors. However, the intended chronic oral administration of imatinib may lead to development of cellular resistance and subsequent treatment failure. Indeed, several molecular mechanisms leading to imatinib resistance have already been reported, including overexpression of the MDR1/ABCB1 drug pump. We examined whether imatinib is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump that is frequently overexpressed in human tumors. Using a panel of well-defined BCRP-overexpressing cell lines, we provide the first evidence that imatinib is a substrate for BCRP, that it competes with mitoxantrone for drug export, and that BCRP-mediated efflux can be reversed by the fumitremorgin C analog Ko-143. Since BCRP is highly expressed in the gastrointestinal tract, BCRP might not only play a role in cellular resistance of tumor cells but also influence the gastrointestinal absorption of imatinib.

journal_name

Blood

journal_title

Blood

authors

Burger H,van Tol H,Boersma AW,Brok M,Wiemer EA,Stoter G,Nooter K

doi

10.1182/blood-2004-04-1398

subject

Has Abstract

pub_date

2004-11-01 00:00:00

pages

2940-2

issue

9

eissn

0006-4971

issn

1528-0020

pii

2004-04-1398

journal_volume

104

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

    abstract::Despite many studies on the pathophysiology of antiphospholipid antibodies (aPL), the mechanism by which aPL causes thrombosis has not been established. We have tried to elucidate the paradox between the prolongation of the clotting time of phospholipid-dependent coagulation tests in vitro and the occurrence of thromb...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Oosting JD,Derksen RH,Bobbink IW,Hackeng TM,Bouma BN,de Groot PG

    更新日期:1993-05-15 00:00:00

  • Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.

    abstract::One of the most serious complications of successful treatments for Hodgkin's disease is an increased incidence of acute nonlymphocytic leukemia (ANLL) and other malignancies. A retrospective analysis carried out on 1032 consecutive patients with Hodgkin's disease admitted to our Institute between 1965 and 1978 and tre...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Valagussa P,Santoro A,Fossati Bellani F,Franchi F,Banfi A,Bonadonna G

    更新日期:1982-03-01 00:00:00

  • 14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling.

    abstract::Members of the 14-3-3 family of proteins function as adapters/modulators that recognize phosphoserine/phosphothreonine-based binding motifs in many intracellular proteins and play fundamental roles in signal transduction pathways of eukaryotic cells. In platelets, 14-3-3 plays a wide range of regulatory roles in phosp...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-09-742650

    authors: Chen Y,Ruggeri ZM,Du X

    更新日期:2018-05-31 00:00:00

  • Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum.

    abstract::Intracellular protein transport in endothelial cells is selectively inhibited by homocysteine, a thiol amino acid associated with both thrombosis and atherosclerosis. In a previous study, homocysteine decreased cell surface expression of the surface transmembrane glycoprotein thrombomodulin without decreasing secretio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lentz SR,Sadler JE

    更新日期:1993-02-01 00:00:00

  • Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors.

    abstract::The rapid recovery of hematopoiesis after allogeneic blood stem cell transplantation has been attributed to the quality and quantity of hematopoietic progenitors in the blood stem cell grafts from filgrastim-stimulated donors. To determine whether further stimulation with filgrastim after transplantation would affect ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood.v97.11.3405

    authors: Przepiorka D,Smith TL,Folloder J,Anderlini P,Chan KW,Körbling M,Lichtiger B,Norfleet F,Champlin R

    更新日期:2001-06-01 00:00:00

  • Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes.

    abstract::Plasmodium falciparum-infected erythrocytes (parasitized red blood cells [PRBCs]) can adhere to uninfected erythrocytes (RBCs) to form rosettes, and adhere to the endothelial cell (EC) surface antigen CD36. These adherence phenomena have previously been considered quite different. We show that anti-CD36 monoclonal ant...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Handunnetti SM,van Schravendijk MR,Hasler T,Barnwell JW,Greenwalt DE,Howard RJ

    更新日期:1992-10-15 00:00:00

  • Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

    abstract::The blockade of platelet integrin glycoprotein (GP) IIb/IIIa is a promising new antiplatelet strategy. The binding of ligands or of the ligand-mimetic peptide RGD causes a conformational change of GP IIb/IIIa from the nonactivated to the activated state. Because several blocking agents/inhibitors are ligand-mimetics, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Peter K,Schwarz M,Ylänne J,Kohler B,Moser M,Nordt T,Salbach P,Kübler W,Bode C

    更新日期:1998-11-01 00:00:00

  • Hepatosplenic candidiasis--a contraindication to marrow transplantation?

    abstract::To determine whether a prior history of hepatosplenic candidiasis resulted in increased Candida-associated morbidity and mortality after marrow transplant, 15 consecutive patients with biopsy-proven hepatosplenic candidiasis were observed prospectively. All patients received amphotericin B before transplant. Amphoteri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bjerke JW,Meyers JD,Bowden RA

    更新日期:1994-10-15 00:00:00

  • Alloantigen presentation and graft-versus-host disease: fuel for the fire.

    abstract::Allogeneic stem cell transplantation (SCT) is a unique procedure, primarily in patients with hematopoietic malignancies, involving chemoradiotherapy followed by the introduction of donor hematopoietic and immune cells into an inflamed and lymphopenic environment. Interruption of the process by which recipient alloanti...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-02-697250

    authors: Koyama M,Hill GR

    更新日期:2016-06-16 00:00:00

  • Fas-mediated apoptosis in cultured human eosinophils.

    abstract::Previous studies have shown that cytokine-dependent eosinophils undergo apoptosis, yet the mechanisms governing this phenomenon remain obscure. Fas antigen is a transmembrane glycoprotein belonging to the tumor necrosis factor receptor family. Cross-linking of Fas antigen in numerous cell types leads to apoptosis. In ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Druilhe A,Cai Z,Hailé S,Chouaib S,Pretolani M

    更新日期:1996-04-01 00:00:00

  • The gene for the alpha 4 subunit of the VLA-4 integrin maps to chromosome 2Q31-32.

    abstract::The VLA-4 integrin (CD49d/CD29), initially discovered on lymphoid cells, is actually known to be highly expressed on T cells, B cells, monocytes, and derived cell lines. Unlike other VLA integrins, mainly involved in cell-matrix adhesive interactions, VLA-4 has also been implicated in several cellular interactions. Ba...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zhang ZH,Vekemans S,Aly MS,Jaspers M,Marynen P,Cassiman JJ

    更新日期:1991-11-01 00:00:00

  • Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42.

    abstract::Blood platelets are anuclear cell fragments that are essential for blood clotting. Platelets are produced by bone marrow megakaryocytes (MKs), which extend protrusions, or so-called proplatelets, into bone marrow sinusoids. Proplatelet formation requires a profound reorganization of the MK actin and tubulin cytoskelet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-03-487942

    authors: Pleines I,Dütting S,Cherpokova D,Eckly A,Meyer I,Morowski M,Krohne G,Schulze H,Gachet C,Debili N,Brakebusch C,Nieswandt B

    更新日期:2013-10-31 00:00:00

  • Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemia.

    abstract::We show further differences between two clinically related entities, T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LL), by using several monoclonal antibodies (MoAbs) reacting with either constant or variable regions of T-cell receptors (TcR) alpha beta and gamma delta or with various CD mo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gouttefangeas C,Bensussan A,Boumsell L

    更新日期:1990-02-15 00:00:00

  • Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells.

    abstract::Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor of the extrinsic coagulation system, synthesized in endothelial cells, which has recently been shown to play an important role in the regulation of activated coagulation factors at the endothelial cell surface. In the present study we investigated t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hansen JB,Olsen R,Webster P

    更新日期:1997-11-01 00:00:00

  • The microenvironment in mature B-cell malignancies: a target for new treatment strategies.

    abstract::Despite major therapeutic advances, most mature B-cell malignancies remain incurable. Compelling evidence suggests that crosstalk with accessory stromal cells in specialized tissue microenvironments, such as the bone marrow and secondary lymphoid organs, favors disease progression by promoting malignant B-cell growth ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2009-06-225326

    authors: Burger JA,Ghia P,Rosenwald A,Caligaris-Cappio F

    更新日期:2009-10-15 00:00:00

  • How I treat chronic graft-versus-host disease.

    abstract::Allogeneic stem cell transplantation (SCT) is now a commonplace procedure. Clinicians who care for patients with hematologic malignancies and aplastic anemia are almost certain to follow up patients after SCT. This review is intended to help clinicians observe patients for probably the most important late complication...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood.v97.5.1196

    authors: Vogelsang GB

    更新日期:2001-03-01 00:00:00

  • Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.

    abstract::We have used monoclonal antibodies (M Abs) and proteolytic fragmentation to localize structurally the functional sites of human von Willebrand factor (vWF) responsible for interaction with membrane glycoproteins GPIb, GPIIb/IIIa, and with collagen. SpII (215 kd) and SpIII (320 kd), the S aureus V-8 protease homodimeri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girma JP,Kalafatis M,Piétu G,Lavergne JM,Chopek MW,Edgington TS,Meyer D

    更新日期:1986-05-01 00:00:00

  • Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays.

    abstract::The ability to transfer new genetic material into human hematopoietic cells provides the foundation for characterizing the organization and developmental program of human hematopoietic stem cells. It also provides a valuable model in which to test gene transfer and long-term expression in human hematopoietic cells as ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dick JE,Kamel-Reid S,Murdoch B,Doedens M

    更新日期:1991-08-01 00:00:00

  • Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.

    abstract::Dasatinib is a BCR-ABL inhibitor with 325-fold higher potency than imatinib against unmutated BCR-ABL in vitro. Imatinib failure is commonly caused by BCR-ABL mutations. Here, dasatinib efficacy was analyzed in patients recruited to phase 2/3 trials with chronic-phase chronic myeloid leukemia with or without BCR-ABL m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-04-214221

    authors: Müller MC,Cortes JE,Kim DW,Druker BJ,Erben P,Pasquini R,Branford S,Hughes TP,Radich JP,Ploughman L,Mukhopadhyay J,Hochhaus A

    更新日期:2009-12-03 00:00:00

  • Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output.

    abstract::The granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin (IL)-3/IL-5 receptor family regulates the production and function of myeloid cells. These cytokines signal through receptor complexes that consist of unique ligand-binding alpha-chains and common signaling beta-chains. IL-5 is distinct from IL-3...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208850

    authors: Beekman JM,Verhagen LP,Geijsen N,Coffer PJ

    更新日期:2009-10-29 00:00:00

  • Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study.

    abstract::Six hundred twelve eligible, previously untreated patients with active multiple myeloma and at least some data available for analysis were entered into a randomized trial (Southwest Oncology Group [SWOG] Phase III myeloma study 8229/30), in which the prognostic significance of pretreatment serum beta 2 microglobulin l...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Durie BG,Stock-Novack D,Salmon SE,Finley P,Beckord J,Crowley J,Coltman CA

    更新日期:1990-02-15 00:00:00

  • Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers.

    abstract::Highly enriched, phenotypically defined hematopoietic stem, Thy-1loLin-Sca-1+, and progenitor cell populations from mouse bone marrow (BM) were tested at limiting dilution for their ability to reconstitute Dexter monolayers. Several classes of BM cells can reconstitute Dexter cultures, first forming discrete "cobblest...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weilbaecher K,Weissman I,Blume K,Heimfeld S

    更新日期:1991-08-15 00:00:00

  • Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

    abstract::Chemotherapy-related myeloid neoplasia (t-MN) is a significant late toxicity concern after cancer therapy. In the randomized intergroup phase 3 E2997 trial, initial therapy of chronic lymphocytic leukemia with fludarabine plus cyclophosphamide (FC) compared with fludarabine alone yielded higher complete and overall re...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-03-342485

    authors: Smith MR,Neuberg D,Flinn IW,Grever MR,Lazarus HM,Rowe JM,Dewald G,Bennett JM,Paietta EM,Byrd JC,Hussein MA,Appelbaum FR,Larson RA,Litzow MR,Tallman MS

    更新日期:2011-09-29 00:00:00

  • Release of iron from phagocytosed Escherichia coli and uptake by neutrophil lactoferrin.

    abstract::Escherichia coli were labeled with 59Fe and then either treated with myeloperoxidase, H2O2, and chloride or opsonized and mixed with human neutrophils. The myeloperoxidase system at pH 7.4 caused release of most of the bacterial 59Fe. A similar result has been obtained by Rosen and Klebanoff (J Biol Chem 257:13731, 19...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Molloy AL,Winterbourn CC

    更新日期:1990-02-15 00:00:00

  • Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload.

    abstract::We compared 48-hour urinary iron excretion after a twice-daily subcutaneous bolus injection of deferoxamine and after 12 hours of subcutaneous continuous infusion of the drug in 27 patients with iron overload (mean age, 55.7 years). In most patients, the iron overload was due to multiple transfusions administered duri...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Franchini M,Gandini G,de Gironcoli M,Vassanelli A,Borgna-Pignatti C,Aprili G

    更新日期:2000-05-01 00:00:00

  • Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.

    abstract::In multiple myeloma (MM), both vascular endothelial (VEGF) and basic fibroblast growth factor (bFGF) promote tumor growth and survival. We have used the novel indolinone BIBF 1000 to study effects of simultaneous inhibition of VEGF, FGF and transforming growth factor-beta on MM cells and their interactions with bone m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4250

    authors: Bisping G,Kropff M,Wenning D,Dreyer B,Bessonov S,Hilberg F,Roth GJ,Munzert G,Stefanic M,Stelljes M,Scheffold C,Müller-Tidow C,Liebisch P,Lang N,Tchinda J,Serve HL,Mesters RM,Berdel WE,Kienast J

    更新日期:2006-03-01 00:00:00

  • Defective polymorphonuclear leukocyte metabolism and function in canine cyclic neutropenia.

    abstract::Humans and grey collie dogs with cyclic neutropenia are known to suffer from an increased rate of bacterial infection. Because of the previously described microanatomic abnormalities of lysosome formation found in the polymorphonuclear leukocytes (PMNs) of dogs with canine cyclic neutropenia, studies of these cells we...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chusid MJ,Bujak JS,Dale DC

    更新日期:1975-12-01 00:00:00

  • Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

    abstract::A global phase 3 study evaluated the pharmacokinetics, efficacy, and safety of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in 63 previously treated male patients (12-61 years) with severe hemophilia B (factor IX [FIX] activity ≤2%). The study included 2 groups: group 1 patients recei...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2015-09-669234

    authors: Santagostino E,Martinowitz U,Lissitchkov T,Pan-Petesch B,Hanabusa H,Oldenburg J,Boggio L,Negrier C,Pabinger I,von Depka Prondzinski M,Altisent C,Castaman G,Yamamoto K,Álvarez-Roman MT,Voigt C,Blackman N,Jacobs I,PROLONG

    更新日期:2016-04-07 00:00:00

  • Interleukin 7 worsens graft-versus-host disease.

    abstract::Impaired immune reconstitution has moved to the forefront of clinical problems limiting progress in allogeneic bone marrow transplantation (BMT). The identification of therapies that can enhance immune reconstitution by increasing thymopoiesis is critical to solving this problem. Interleukin 7 (IL-7) is the most poten...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-04-1082

    authors: Sinha ML,Fry TJ,Fowler DH,Miller G,Mackall CL

    更新日期:2002-10-01 00:00:00

  • Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS.

    abstract::Whole saliva samples collected from available people at risk in Boston for infection with human T-lymphotropic virus type III (HTLV-III/LAV), from late 1984 through early 1985, were analyzed for the presence of antibodies to viral proteins. Fourteen of 20 (70%) acquired immunodeficiency syndrome (AIDS) patients and 14...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Archibald DW,Zon L,Groopman JE,McLane MF,Essex M

    更新日期:1986-03-01 00:00:00